How to Buy Agomab Therapeutics Nv Stock

Agomab Therapeutics Nv

AgomAb Therapeutics NV, a clinical-stage biopharmaceutical company, develops novel disease-modifying therapies for immunology and inflammatory diseases with a focus on chronic fibrotic indications with unmet medical needs.

Agomab Therapeutics Nv stock last closed at $11.05, up 3.27% from the previous day, and has decreased N/A in one year. It has underperformed other stocks in the Biotechnology industry by N/A percentage points. Agomab Therapeutics Nv stock is currently +22.78% from its 52-week low of $9.00, and -36.69% from its 52-week high of $17.45.

As of Apr 24, 2026, there are 48.74M shares of AGMB outstanding. The market value of AGMB is $538.54M. In the past 24 hours, 59,600 AGMB shares were traded.

How to Buy Agomab Therapeutics Nv Stock

Not sure how to invest in Agomab Therapeutics Nv stock? Here's how.

  1. Decide where to buy Agomab Therapeutics Nv stock: You need to decide on a stock brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you decide where to buy Agomab Therapeutics Nv stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've identified.
  3. Put funds into your brokerage account: Select your payment method and add your info.
  4. Evaluate Agomab Therapeutics Nv stock: The Agomab Therapeutics Nv ticker symbol is AGMB. Is Agomab Therapeutics Nv stock a good investment? Should you buy shares of AGMB? How do AGMB's underlying business fundamentals look? Do top analysts think Agomab Therapeutics Nv is a good buy? Why has AGMB's stock price moved recently? (Hint: Our stock market analysis tools can help you figure out if AGMB is a good stock to buy).
  5. Execute your AGMB buy order: Decide if you will purchase AGMB shares at the current market price or use a limit order to buy AGMB shares at a particular price.
  6. Monitor your AGMB position: Create a watchlist to important updates regarding your investment in Agomab Therapeutics Nv shares.

Step 1: Decide where to buy Agomab Therapeutics Nv stock

You need an online brokerage account to access the NASDAQ market and buy AGMB shares.

A brokerage account is an investment account that allows you to buy and sell a variety of financial instruments, including stocks, bonds, mutual funds, and ETFs.

Our favorite brokerage: eToro

Based on our research, eToro is the best stock brokerage. Here's why:

  • Invest in stocks with zero commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to global financial markets: From Technology to Financial Services, New York to Hong Kong (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's leading stock exchanges.
  • Social investing: eToro offers a community of more than 20 million users around the world. Talk to, learn from, and copy the unique crypto portfolios of other investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other assets: Such as ETFs and cryptos.

Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've picked your brokerage, it's time to fill out some personal details so you are able to invest in AGMB stock today.

How to Open a New Brokerage Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Input your personal info to open a new trading account.
  1. Send your data by pressing the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Put funds into your brokerage account

Now that you have filled out your info on app for investing, you need to deposit funds:

Watch the video below if you need help depositing money into your brokerage account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Evaluate Agomab Therapeutics Nv stock

After you have decided on the best place to buy Agomab Therapeutics Nv stock, it's critical to research their stock before you invest, so you truly comprehend the risk as well as the upside.

Agomab Therapeutics Nv shares at a glance

AGMB Price
$11.05
1w %
-2.47%
1y %
N/A
5y %
N/A
P/E
-0.07x
P/B
3.54x
P/S
N/A
PEG
N/A
Revenue
$0.00
Earnings
-$72.73M
Fore. Rev. Growth
N/A
Fore. Earn. Growth
N/A
Market Cap
$538.54M
Next Earnings
N/A
Next Dividend
N/A

Fundamentals of Agomab Therapeutics Nv

WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.

You can view all of the due diligence checks on AGMB's stock page.

How is AGMB stock valued?

Investors use many financial metrics, analyses, models, and charts to gauge AGMB's true value.

Using relative valuations measures:

  • AGMB could be undervalued based on its P/B ratio of 3.54x, relative to Biotechnology industry P/B ratio of 4.93x

You can access more valuation analysis on AGMB's stock here.

AGMB Financial Health Summary

Positive Financial Indicators:

  • There are more short-term assets than short-term liabilities on the AGMB balance sheet.
  • AGMB has cash burn of 60168604. It has sufficient cash and short-term investments to cover this for at least one year.
  • AGMB has $135.48M in cash and short term investments. This is sufficient to cover its annual cash burn of $60.17M.
  • There are more short-term assets than long-term liabilities on the AGMB balance sheet.
  • AGMB has a low debt to equity ratio of 0.17.

Do Wall Street analysts think it's a good time to buy Agomab Therapeutics Nv stock

Out of 3 Equities analysts who track AGMB, the consensus analyst rating on Agomab Therapeutics Nv is a Strong Buy

It's important to keep in mind that analyst forecasts are not recommendations, nor are they investment advice.

You can dig deeper into what analysts are projecting on the Agomab Therapeutics Nv stock forecast page.

AGMB Momentum

SMA10
10.81
SMA20
10.73
SMA50
12.91
SMA100
N/A
SMA200
N/A
MACD
-0.56
MACD Signal
-0.74
MACD Histogram
0.19
RSI
48.82
Stochastic %K
60.4
Stochastic %D
59.1
StochRSI %K
66.64
StochRSI %D
63.89

What are AGMB insiders up to?

Over the last 12 months, insiders at AGMB have not bought or sold any shares.

Learn more about who owns AGMB shares here.

Can I rely on AGMB as an income stream?

No, Agomab Therapeutics Nv doesn't provide an income stream by paying out dividends.

Get analysis from other investors

One of the reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other community members have to say.

Step 5: Execute your AGMB buy order

There are two primary order types:

  • Market order: A market order is an order to buy or sell a stock at the best price on the market.
    Market orders are mostly the best for newer investors.
  • Limit order: A limit order is an order to buy or sell a stock at a specific price (or better).
    If you want to make sure you're buying or selling at a given dollar amount, place a limit order.

Hit the Open Trade button and eToro will execute the order.

If you want additional help buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Monitor your AGMB position

Now that you own some shares in AGMB, you'll want to keep up with your new investment.

Make a watchlist to get alerted to the latest events about your AGMB stock.

AGMB Feed

How to Buy Stock in Agomab Therapeutics Nv

To summarize, here are the 6 steps you need to take to buy Agomab Therapeutics Nv stock right now:

  1. Decide where to buy Agomab Therapeutics Nv stock
  2. Sign up for a brokerage account
  3. Put funds into your brokerage account
  4. Evaluate Agomab Therapeutics Nv stock
  5. Execute your AGMB buy order
  6. Monitor your AGMB position

If you need a brokerage account, eToro is our favorite option.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to keep an eye on your new investment in Agomab Therapeutics Nv, get started below.

NASDAQ: AGMB
$11.05+0.35 (+3.27%)
Updated Apr 24, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: AGMB
$11.05+0.35 (+3.27%)
Updated Apr 24, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Agomab Therapeutics Nv share?

As of Apr 24, 2026, it costs $11.05 to buy one share of Agomab Therapeutics Nv stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $5, you can buy 0.452 shares of AGMB.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Is now a good time to buy Agomab Therapeutics Nv stock?

According to 3 Wall Street analysts who monitor Agomab Therapeutics Nv, their consensus recommendation is to buy Agomab Therapeutics Nv stock.

What is the best way to buy Agomab Therapeutics Nv stock?

One way to place an order for Agomab Therapeutics Nv stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.